Accelerated approval for Filspari was granted based on data from the Phase III PROTECT study, which showed that the small molecule blocker lowered urine protein levels more than three times as much as the active control, Avapro
Spielmann, T., Gardiner, D
Endocr Rev (1993) 14(6):74793
Sequential cerebral autoradiography indicated that AngIV caused the redistribution of blood flow to ischemic areas within a few minutes
Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
In this 2013 clinical study by Prussick, Prussick, and Gutman, they discovered that administering a nondenatured bioactive whey protein isolate (which had previously been demonstrated to improve glutathione levels) did indeed improve symptoms of psoriasis